Logo

American Heart Association

  1
  0


Final ID: WMP93

Long-term Outcomes of Total endovascular Reconstruction of Symptomatic Internal Carotid Artery Chronic Total Occlusions: An 18-year Experience

Abstract Body: Background: Chronic total internal carotid artery occlusion (CTO) can be associated with a high (22-25%) annual risk of stroke with limited therapeutic options. Total endovascular reconstruction (TER) is increasingly feasible but mid-term and long-term outcomes have not been reported.

Methods: Data from all patients treated with carotid CTO treated with TER over the past 18years were collected in a database. Patients were selected based on the presence of angiographically proven symptomatic carotid occlusion, adequate landing zone and concurrent impairment of cerebrovascular reserve or recurrent ischemia despite maximal medical therapy. They were treated via a femoral approach using conventional CTO techniques with balloon expandable and/or self-expanding stents. Neurological evaluation of NIHSS, mRankin and carotid U/S were performed at discharge, 30days, and all subsequent follow-up. All TIA, stroke, death, and MI were recorded during follow-up. Angiographic follow-up was performed between 6-12months when possible.

Results: Twenty-six symptomatic patients with a mean age of 65±7.8years were treated. Technical success was achieved in 22/26 (85%) on first attempt and in 3/4 on second attempt for total success rate of 25/26(96%). Total 30-day stroke/death/MI was 6.9% (2 ICH, both in first 3 years of experience). There were no recurrent events during 15.2±9.8months (median 12) of follow-up. Restenosis was found in 5/26 (19.2%) of patients; 2/5 were in unstented segments of the ICA. There was one case of asymptomatic carotid occlusion at 7months. The median mRS dropped from 2 to 1 at follow-up.

Conclusion: TER is feasible in most patients with carotid CTO and is associated with a 30-day event rate lower than reported for STA-MCA bypass surgery. It is associated with good long-term stroke reduction despite a 19.2% risk of restenosis. Carotid re-occlusion is rare. Randomized trials are needed to validate this approach.
  • Chebl, Alex  ( Henry Ford Health System , Bingham Farms , Michigan , United States )
  • Author Disclosures:
    Alex Chebl: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Consultant:Contego Medical:Active (exists now) ; Consultant:Silk Road Medical:Active (exists now) ; Consultant:Cerenovus:Active (exists now)
Meeting Info:
Session Info:

Neuroendovascular Moderated Poster Tour I

Wednesday, 02/05/2025 , 06:00PM - 07:00PM

Moderated Poster Abstract Session

More abstracts on this topic:

A blood test based on RNA-seq and machine learning for the detection of steatotic liver disease: A Pilot Study on Cardiometabolic Health

Poggio Rosana, Berdiñas Ignacio, La Greca Alejandro, Luzzani Carlos, Miriuka Santiago, Rodriguez-granillo Gaston, De Lillo Florencia, Rubilar Bibiana, Hijazi Razan, Solari Claudia, Rodríguez Varela María Soledad, Mobbs Alan, Manchini Estefania

Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis: CREST-2 Update

Meschia James, Chaturvedi Seemant, Chimowitz Marc, Demaerschalk Bart, Howard Virginia, Huston John, Lazar Ronald, Moore Wesley, Benson Richard, Voeks Jenifer, Brott Thomas, Howard George, Lal Brajesh, Jones Michael, Heck Donald, Turan Tanya, Roubin Gary, Brown Robert, Barrett Kevin

More abstracts from these authors:
The Rapid Occluded Vessel Etiology Score: A Novel Algorithm to Identify Acute Atherosclerotic Large Vessel Occlusions of the Middle Cerebral Artery

Fana Michael, Marin Horia, Choudhury Omar, Chebl Alex, Latack Katie, Schultz Lonni, Albanna Abdalla, Reardon Taylor, Iqbal Zahid, Kole Max

Plasma small extracellular vesicles derived from patients with cerebral aneurysms impair cerebral endothelial permeability and promote angiogenesis

Chebl Alex, Zhang Jing, Aldilaimi Akram, Teng Hua, Li Yanfeng, Chopp Michael, Zhang Zheng Gang

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)